Medicare Enrolled
Dr. Paul Tucker, M.D.
Interventional Cardiology · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tucker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tucker? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tucker
Dr. Paul Tucker is an interventional cardiology in Austin, TX, with 20 years in practice. Based on federal Medicare data, Dr. Tucker performed 6,487 Medicare services across 4,972 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tucker received a total of $15,900 from 50 pharmaceutical and/or device companies across 766 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tucker is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 8% volume in TX$ $15,900 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,487
Medicare services
Top 8% in TX for interventional cardiology
4,972
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~324 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,212 | $87 | $206 |
| Electrocardiogram (EKG), 12-lead | 1,261 | $10 | $60 |
| Office visit, established patient, complex (40-54 min) | 359 | $130 | $278 |
| Echocardiogram, transthoracic | 266 | $50 | $213 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 261 | $11 | $47 |
| Remote pacemaker monitoring, 90 days | 240 | $21 | $106 |
| Remote pacemaker/defibrillator monitoring, 90 days | 234 | $17 | $98 |
| Office visit, established patient (20-29 min) | 151 | $58 | $139 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 146 | $16 | $70 |
| Ultrasound of both sides of head and neck blood flow | 105 | $28 | $92 |
| Hospital follow-up visit, moderate complexity | 105 | $62 | $141 |
| New patient office visit (45-59 min) | 102 | $110 | $320 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 100 | $2 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 99 | $5 | $24 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 92 | $60 | $278 |
| Hospital follow-up visit, high complexity | 67 | $92 | $202 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 66 | $9 | $39 |
| New patient office visit, complex (60-74 min) | 61 | $161 | $398 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 52 | $10 | $45 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 52 | $14 | $72 |
| Heart muscle strain imaging | 51 | $9 | $38 |
| Initial hospital admission, high complexity | 46 | $126 | $393 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 39 | $26 | $102 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 37 | $26 | $106 |
| Ultrasound of heart with probe in esophagus, with report | 28 | $78 | $334 |
| Ultrasound of heart blood flow, valves and chambers | 28 | $14 | $59 |
| Ultrasound of leg arteries or artery grafts | 28 | $27 | $88 |
| EKG interpretation and report | 27 | $6 | $27 |
| Ultrasound of heart, follow-up | 25 | $16 | $83 |
| Ultrasound study of arm and leg arteries | 25 | $9 | $38 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 22 | $14 | $70 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 22 | $39 | $276 |
| Cardiac catheterization | 20 | $171 | $983 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 19 | $66 | $375 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $276 | $1,232 |
| External shock to heart to regulate heart beat | 13 | $81 | $390 |
| Hospital discharge day management, 30 minutes or less | 12 | $65 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.1% high complexity
13.0% medium
70.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,900
Total received (2018-2024)
Avg $2,271/year across 7 years
Top 28% in TX for interventional cardiology
50
Companies
766
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,778 (86.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,052 (12.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$70 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,630
2023$1,777
2022$1,590
2021$3,533
2020$3,533
2019$2,018
2018$1,819
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Osprey Medical Inc
$4,079
Amgen Inc.
$1,658
Novartis Pharmaceuticals Corporation
$1,361
ABIOMED
$867
Janssen Pharmaceuticals, Inc
$832
Novo Nordisk Inc
$668
AstraZeneca Pharmaceuticals LP
$576
ShockWave Medical, Inc
$416
Shockwave Medical, Inc
$407
PFIZER INC.
$388
Medtronic Vascular, Inc.
$388
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$370
Regeneron Healthcare Solutions, Inc.
$368
Abbott Laboratories
$334
SANOFI-AVENTIS U.S. LLC
$333
Medtronic, Inc.
$312
E.R. Squibb & Sons, L.L.C.
$283
Amarin Pharma Inc.
$220
ATRICURE, INC.
$211
CORDIS US CORP.
$155
Actelion Pharmaceuticals US, Inc.
$139
Cardinal Health 200 LLC
$128
Terumo Medical Corporation
$124
iRhythm Technologies, Inc.
$122
Medicure Pharma Inc.
$119
AtriCure, Inc.
$103
Esperion Therapeutics, Inc.
$78
Penumbra, Inc.
$72
Astellas Pharma US Inc
$70
Vital Connect, Inc
$69
LeMaitre Vascular, Inc.
$61
Akcea Therapeutics, Inc.
$61
Boston Scientific Corporation
$57
Acist Medical Systems, Inc.
$51
Lundbeck LLC
$50
Kiniksa Pharmaceuticals International, plc
$40
CARDIVA MEDICAL, INC.
$38
Alnylam Pharmaceuticals Inc.
$37
Merck Sharp & Dohme LLC
$34
Cardinal Health 200, LLC
$33
Kiniksa Pharmaceuticals, Ltd.
$32
Gilead Sciences, Inc.
$27
Cleerly, Inc.
$24
Edwards Lifesciences Corporation
$20
CHIESI USA, INC.
$17
ARBOR PHARMACEUTICALS, INC.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Impulse Dynamics (USA) Inc.
$14
AGEPHA Pharma FZ LLC
$13
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 44.6% of total payments
Associated products mentioned in payments ›
AMPLATZER AMULET · ATRICURE ATRICLIP LAA EXCLUSION · AZURE XT DR MRI SURESCAN · Advisa · Amplia MRI · AngioSeal · Arcalyst · Assurity Pacemaker · Azure · BRILINTA · CAMZYOS · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · CVI Systems · Cleerly Ischemia · Cobalt · Corlanor · DyeVert · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EPIC · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · GlideWire · Glidesheath · HMG-CoA reductase inhibitor. · Impella · Indigo System · JOT DX · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LODOCO · LifeVest · Livalo · MITRACLIP · MULTAQ · MYNX CONTROL · Merlin Connectivity and Remote · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OUTBACK · OUTBACK Elite · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRECISE · PRECISE PRO RX · RXi Systems · Repatha · Rybelsus · S.M.A.R.T. CONTROL Self-Expanding Nitinol Stent · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY ABLATION SYSTEM · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher · TEGSEDI · UPTRAVI · VERQUVO · VITALPATCH RTM · VYNDAQEL · Vascepa · Vascular Closure Device · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XENOSURE · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $245 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
23
Per 100K population
1.8
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tucker is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tucker experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tucker performed 2,212 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tucker receive payments from pharmaceutical companies?
Yes. Dr. Tucker received a total of $15,900 from 50 companies across 766 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tucker's costs compare to other interventional cardiologys in Austin?
Dr. Tucker's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tucker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Austin
Browse interventional cardiologys in Austin ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Osprey Medical Inc Payments to Doctors
See all physicians who received payments from Osprey Medical Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology